| 1 |
Wang Z, Xiong Y, Peng Y, Zhang X, Li S, Peng Y, Peng X, Zhuo L, Jiang W. Natural product evodiamine-inspired medicinal chemistry: Anticancer activity, structural optimization and structure-activity relationship. Eur J Med Chem 2023;247:115031. [PMID: 36549115 DOI: 10.1016/j.ejmech.2022.115031] [Reference Citation Analysis]
|
| 2 |
Liang Y, Zhang H, Zhang X, Peng Y, Deng J, Wang Y, Li R, Liu L, Wang Z. Discovery of evodiamine derivatives as potential lead antifungal agents for the treatment of superficial fungal infections. Bioorg Chem 2022;127:105981. [PMID: 35785554 DOI: 10.1016/j.bioorg.2022.105981] [Reference Citation Analysis]
|
| 3 |
Shen J, Li J, Yu P, Du G. Research Status and Hotspots of Anticancer Natural Products Based on the Patent Literature and Scientific Articles. Front Pharmacol 2022;13:903239. [DOI: 10.3389/fphar.2022.903239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Lei F, Xiong Y, Wang Y, Zhang H, Liang Z, Li J, Feng Y, Hao X, Wang Z. Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives as Potential Antihepatocellular Carcinoma Agents. J Med Chem 2022;65:7975-92. [PMID: 35639640 DOI: 10.1021/acs.jmedchem.2c00520] [Reference Citation Analysis]
|
| 5 |
Fakhri S, Moradi SZ, Yarmohammadi A, Narimani F, Wallace CE, Bishayee A. Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy. Front Oncol 2022;12:834072. [PMID: 35299751 DOI: 10.3389/fonc.2022.834072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 6 |
Deng X, Luo T, Li Z, Wen H, Zhang H, Yang X, Lei F, Liu D, Shi T, Zhao Q, Wang Z. Design, synthesis and anti-hepatocellular carcinoma activity of 3-arylisoquinoline alkaloids. Eur J Med Chem 2022;228:113985. [PMID: 34802836 DOI: 10.1016/j.ejmech.2021.113985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Hao X, Deng J, Zhang H, Liang Z, Lei F, Wang Y, Yang X, Wang Z. Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents. Bioorg Med Chem 2021;55:116595. [PMID: 34990980 DOI: 10.1016/j.bmc.2021.116595] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 8 |
Xu S, Yao H, Qiu Y, Zhou M, Li D, Wu L, Yang DH, Chen ZS, Xu J. Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer. J Med Chem 2021;64:17346-65. [PMID: 34844412 DOI: 10.1021/acs.jmedchem.1c01411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Liang Z, Lei F, Deng J, Zhang H, Wang Y, Li J, Shi T, Yang X, Wang Z. Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer. Eur J Med Chem 2021;:113960. [PMID: 34774339 DOI: 10.1016/j.ejmech.2021.113960] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
